Divisions
- Laboratory of recombinant vaccines
- Laboratory of Immunochemistry
- Laboratory of Recombinant Technologies
- Hybridoma technology sector
The main directions
- Development of preventive vaccines against viral infections
- Development of drugs based on immunoglobulins for the treatment and emergency prevention of diseases caused by viral pathogens
Contacts
Phone: + 7 (383) 3634700 ext. 2617
E-mail: ilyichev@vector.nsc.ru